Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Polonsky

Showing results (761-770 of 850) with videos related to

Pageof 85
Sort By:
Vascular Medicine (London, England)|April 7, 2023
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) studyE Hope Weissler, Amanda Stebbins, Lisa Wruck, et al.
Atherosclerosis|September 21, 2014
High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristicsTamar S Polonsky, Kiang Liu, Lu Tian, et al.
JAMA Cardiology|April 14, 2017
Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical TrialMary M McDermott, Christiaan Leeuwenburgh, Jack M Guralnik, et al.
JAMA|October 4, 2022
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical TrialMary M McDermott, Lydia Bazzano, Charlotte A Peterson, et al.
Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.
JACC. Cardiovascular Imaging|November 14, 2016
Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease EventsMary M McDermott, Christopher M Kramer, Lu Tian, et al.
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
Journal of Epidemiology and Global Health|February 19, 2024
Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in GuineaMory Keita, Ibrahima Sory Cherif, Jonathan A Polonsky, et al.
Circulation|July 31, 2015
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol GuidelinesJoseph Yeboah, Tamar S Polonsky, Rebekah Young, et al.
Journal of the American Heart Association|May 12, 2020
Correlations of Calf Muscle Macrophage Content With Muscle Properties and Walking Performance in Peripheral Artery DiseaseKate Kosmac, Marta Gonzalez-Freire, Mary M McDermott, et al.
Pageof 85

Showing results (761-770 of 850) with videos related to

Sort By:
Pageof 85
Vascular Medicine (London, England)|April 7, 2023
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) studyE Hope Weissler, Amanda Stebbins, Lisa Wruck, et al.
Atherosclerosis|September 21, 2014
High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristicsTamar S Polonsky, Kiang Liu, Lu Tian, et al.
JAMA Cardiology|April 14, 2017
Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical TrialMary M McDermott, Christiaan Leeuwenburgh, Jack M Guralnik, et al.
JAMA|October 4, 2022
Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical TrialMary M McDermott, Lydia Bazzano, Charlotte A Peterson, et al.
Clinical Trials (London, England)|February 5, 2021
Clinician engagement in the ADAPTABLE (Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness) trialAjar Kochar, Mary B Summers, Catherine P Benziger, et al.
JACC. Cardiovascular Imaging|November 14, 2016
Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease EventsMary M McDermott, Christopher M Kramer, Lu Tian, et al.
JACC. Clinical Electrophysiology|November 30, 2023
Sex-Related Differences in Ventricular Tachyarrhythmia Events in Patients With Implantable Cardioverter-Defibrillator and Prior Ventricular TachyarrhythmiasBartosz Krzowski, Valentina Kutyifa, Margot Vloka, et al.
Journal of Epidemiology and Global Health|February 19, 2024
Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in GuineaMory Keita, Ibrahima Sory Cherif, Jonathan A Polonsky, et al.
Circulation|July 31, 2015
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol GuidelinesJoseph Yeboah, Tamar S Polonsky, Rebekah Young, et al.
Journal of the American Heart Association|May 12, 2020
Correlations of Calf Muscle Macrophage Content With Muscle Properties and Walking Performance in Peripheral Artery DiseaseKate Kosmac, Marta Gonzalez-Freire, Mary M McDermott, et al.
Pageof 85